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The specific antibody responses of mice to thymus-dependent polypeptide antigens are 
controlled by autosomal dominant immune response (Ir) genes which map in the I region 
of the H-2  complex (1). Primary responses in vivo or in vitro to the linear copolymers 
GAT  ~ (L-glutamic acide°-L-alanine3°-L-tyrosine  ~°) and GA (L-glutamic acidJ°-L-alanine  5°) 
are restricted to the IgG class in responder mice (2-4).  Similarly, in nonresponder mice 
primary responses to these  antigens  complexed to methylated bovine serum albumin 
(MBSA) and to GT (L-glutamic acidJ°-L-tyrosine  5°) as GT-MBSA are also restricted to the 
IgG class  (2,  4,  5).  These  results  are  in  sharp  contrast  with the  early primary IgM 
responses to many conventional antigens such as sheep red blood cells (SRBC) bacterial 
antigens and to other synthetic polypeptide antigens (6, 7). Primary immunization with 
the linear terpolyper of L-glutamic acid, L-lysine, and L-phenylalanine (GLO) stimulates 
production of antibodies of the IgM and IgG class in responder animals but no responses 
in  mice lacking the  appropriate  a ÷ and  fl+ GLO genes  (8,  9),  whereas the branched 
copolymers studied by McDevitt and Sela have been shown to stimulate IgM antibody 
responses  in  both  responder  and  nonresponder  animals  and  IgG antibodies,  only  in 
responder strains (10, 11). The prevalent immunological dogma that the synthesis of IgM 
antibodies always precedes the development of  IgG-forming cells as the initial response to 
antigen  should,  therefore,  be  re-examined.  In  this  study,  we  have  investigated  the 
conditions  necessary for the  synthesis  of specific IgM antibodies  against  GAT in re- 
sponder strains and against GAT-MBSA or GT-MBSA in nonresponder strains of mice. In 
contrast to many classical antigens referred to above, specific IgM antibody responses to 
these antigens require secondary immunization. 
Previous  studies  from  our  laboratory  demonstrated  that  immunization  of 
nonresponder  mice with  GAT or  GT stimulates the  development of specific T 
cells capable of suppressing the primary IgG responses to GAT-MBSA (12) and 
GT-MBSA,  respectively  (5).  The  ability  to  elicit  secondary IgM responses  to 
these antigens permitted us to verify that such responses are also suppressed in 
nonresponder animals by preimmunization with the uncomplexed copolymers. 
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Materials and Methods 
Mice.  BALB/c mice were obtained from Health Research, Inc., West Seneca, New York. DBA/ 
1 and C57BL/6 mice were obtained from The Jackson Laboratory, Bar Harbor, Maine. Mice used in 
these experiments were 10-16 wk of age and were maintained on laboratory chow and acidified- 
chlorinated water a d lib. 
Antigens.  The  random  synthetic  terpolymer  of  I~glutamic  acide°-L-alanine3°-L-tyrosine  1° 
(GAT),  average tool wt 30,800 daltens and the copolymer of L-glutamic acidS°-L-tyrosine  5° (GT), 
average mol wt 32,000, were purchased from Miles Laboratories, Inc.,  Miles Research Division, 
Elkhardt, Ind. Stock solutions (10 ~g/ml) were prepared in normal saline containing 1% Na2CO3 at 
pH 9.0-9.5.  MBSA was purchased from Worthington Biochemical Corp., Freehold, N.J. 
Immunizations.  Primary antibody responses were elicited by injecting mice intraperitoneally 
with 10, 50, or 100 ~g GAT, 10 ~g GAT as GAT-MBSA, or 10 ~g GT as GT-MBSA in a  mixture 
containing 2  x  10  ~ killed Bordetella pertussis  organisms and 10 /~g of an aluminum-magnesium 
hydroxide gel (Maalox, W. H. Rorer, Inc., Fort Washington, Pa.). 7 days afar injection, spleens 
were assayed for GAT- or GT-specific plaque-forming cells (PFC)  (2).  To investigate secondary 
antibody responses, mice were initially immunized intraperitoneally with 50/~g GAT, 50/~g GAT 
as GAT-MBSA or 50  ~g GT as GT-MBSA in a  mixture containing pertussis and/or Maalox or 
Maalox alone as indicated in the tables. A second injection of 10 ~g of antigen followed 3 or 21 days 
later.  Spleens from injected animals were assayed for GAT- or GT-specific PFC 4-11 days after 
second injection. 
To  investigate  suppression  of the  secondary  antibody  response  of nonresponder  mice,  the 
animals were first injected with 100 ~g GT in Maalox (BALB/c) or 10 ~g GAT in Maalox (DBA/1). 
3  and  6  days  later,  mice  were  injected  with  GT-MBSA  (BALB/c)  and  GAT-MBSA  (DBA/1) 
according to the repeated immunization protocol described above. 
Antigen-Binding  Assay.  The primary  and secondary GAT-specific circulating antibody re- 
sponses of BALB/c mice were measured.  Serum samples were diluted 1/5 in phosphate-buffered 
saline (PBS) and then assayed by a  modified Farr assay described previously (13). 
Sephadex  G-200 Gel Filtration.  The  separation of IgM  and  IgG  anti-GAT antibodies was 
performed  by  gel  filtration  on  a  1.5  x  90  cm  Sephadex  G-200  (Pharmacia  Fine  Chemicals, 
Piscataway,  N.  J.)  column.  The  gel  was  equilibrated at  4°C  in  PBS,  and the  flow  rate  was 
maintained at 5 ml/h with a peristaltic pump. The column was calibrated using Blue dextran 2,000 
(2  x  10  e tool wt,  Pharmacia Fine Chemicals), bovine gamma globulin (BGG,  150,000  tool wt), 
bovine serum albumin (BSA, 66,000 mol wt), and cytochrome c  (12,500 mol wt) as markers. 
The optical density of the eluate was recorded with an LKB UV recorder. BALB/c mice were 
immunized  twice  with  GAT  in  Maalox  pertussis  as  described  above;  7  days  after  the  second 
injection (day 10) the mice were bled. 0.5 ml of heat-inactivated (56°C 30 rain) serum was loaded on 
the column. The optical density of the eluted material was recorded and the hemagglutinin titer of 
the various fractions measured using GAT-SRBC as indicator cells. 
Hemolytic Plaque Assay.  The antibody responses to  GAT,  GAT-MBSA,  or GT-MBSA were 
assayed by a modification of the Jerne hemolytic plaque technique described previously (2). GAT 
was coupled to SRBC as described previously (2). As in previous studies, GAT-SRBC were used to 
detect GAT or GT-specific PFC because of the extensive cross-reactivity of the antibody produced. 
IgM PFC were enumerated after incubation of GAT-SRBC and spleen cells using guinea pig serum 
as a  source of C +.  A  goat anti-mouse p-chain antiserum prepared against MOPC-104E  and ab- 
sorbed with k-light chains (a gift from Dr. R. Asofsky) was used to inhibit IgM PFC (14). IgG PFC 
were developed with polyvalent rabbit anti-mouse IgG serum and C' in the presence of goat anti- 
~-chain antibody (2,  14).  Both IgM and IgG antigen-specific plaques were determined by sub- 
tracting the number of PFC obtained in the presence of a  suitable dilution of GAT  (25 ~g/ml) 
from the number of plaques detected on GAT-SRBC in the absence of the specific inhibitor (4). 
Results 
Effect of Repeated Immunization  on the PFC Responses of BALB/c Mice to 
GAT.  Previous studies have shown that genetic responder and nonresponder 
mice fail to develop a primary IgM GAT-specific PFC response in vivo or in vitro 
(2). Primary in vivo PFC responses to the copolymers GA and GT, likewise, have 1280  CONTROL  OF  IgG  AND  IgM  RESPONSES 
TABLE  I 
Effect of Repeated Immunization on the IgM and IgG PFC Responses of  BALB/c Mice to 
GAT 
Immunization*  No. of mice  GAT-specific  PFC per spleen 
Day 0  Day 3  Day 21  per group  IgM  IgG 
Arith. mean +_ SE 
Exp. I 
-  -  -  5  600 _+ 200  <400 
-  GAT/MP$  -  11  673 --- 220§  12,363 -+ 4,590 
-  GAT/MI~I  -  5  425 + 175  14,700 _+ 4,834 
MP  GAT/MP  -  11  1,163 -+ 484  5,218 +_ 1,273 
GAT/M  GAT/MP  -  11  9,473 ___ 3,574  24,036 _+ 5,968 
GAT/MP  GAT/MP  -  11  21,163 -+ 3,854  34,781 _+ 4,908 
Exp. II 
GAT/MP  GAT/MP  -  6  12,666 + 3,324  22,766 -+ 2,508 
GAT/MP  -  GAT/MP  6  10,133 +_ 985  19,766 -+ 3,553 
* Mice were immunized intraperitoneally,  day 0, with 50 ~g GAT in Maalox with or without 2 x 
l0  s killed Bordetella pertussis organisms or with Maalox and pertussis alone. 3 or 21 days later 
the mice received 10 ~g GAT in Maalox and pertussis. 7 days later, spleen cells were assayed for 
GAT-specific PFC. 
Mice received a single injection of 10 ~g GAT in Maalox-pertussis. 
§ IgM response not significantly different (P = 0.461) from no antigen control. 
II Mice received a single injection of 100 ~g GAT in Maalox-pertussis. 
been  found to  be  restricted  to the  IgG class  (4).  In  addition,  a  primary IgM 
response to GT could not be detected in mice pretreated with cyclophosphamide 
in order to remove suppressor T cells (Waltenbaugh, unpublished observations). 
In experiments relating the structure of GAT with its antigenic properties,  we 
have observed a  marked enhancement in the number of GAT-specific PFC's in 
mice that  had received two injections  of GAT in  Maalox pertussis  (15).  Mice 
receiving two injections of GAT, at a  3-day interval,  display a  two to threefold 
increase in the number of IgG PFC's (Table I, Experiment I).  Moreover, after 
two injections  of GAT,  GAT-specific PFC's of the  IgM class  are  elicited.  The 
occurrence of IgM  PFC's is  due  to  repeated  immunization  with  the  antigen; 
Maalox  pertussis  followed  by  GAT  in  Maalox  pertussis  does  not  cause  the 
formation  of significant  numbers  of GAT-specific IgM  plaques.  The  highest 
numbers  of both  IgM  and  IgG  GAT-specific PFC's were  seen  after  repeated 
injections of GAT in Maalox pertussis.  The time period between the first and 
second injection of GAT in Maalox pertussis may be extended up to 3 wk (Table 
I, Experiment II), without any effect upon either the IgM or IgG PFC responses. 
Effect of Repeated Immunization of Serum Antibody.  We have analyzed the 
sera of animals receiving secondary immunization with GAT both by a modified 
Farr assay and passive hemagglutination. The data presented in Table II show 
that significant antigen binding, using the condition of our assay, is detected in 
the sera only after the secondary immunization with GAT. In contrast, the sera 
obtained after a  single  GAT injection do not show significant binding.  In the 
hemagglutination  assay,  using  GAT-SRBC as  indicator  cells,  mice  receiving 
two injections of GAT gave a  titer of 1/1,024,  whereas a  titer of 1/32  was seen C.  WALTENBAUGH,  J.  THEZE,  AND  B.  BENACERRAF 
TABLE  II 
Effect of Repeated Immunization with GAT on the Antibody Responses 
of BALB/c Mice 
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Immunization* 
Day 0  Day 3 
No. mice  Percent binding 
of GAT:  P value 
per group  Day 10 
-  GAT/MP  7  4.8 _+ 1.95  - 
MP  GAT/MP  7  4.3 _+ 0.68  0.80 
GAT/MP  GAT/MP  7  33.9 _+ 2.45  <0.001 
GAT/M  GAT/MP  7  28.5 ___ 5.25  0.001 
* Mice were immunized intraperitoneally with 50 tzg GAT in Maalox with or 
without pertussis or with Maalox and pertussis alone. 3 days later the mice 
received 10 tzg GAT in Maalox and pertussis. 7 days later sera were collected 
and assayed at 1/5 dilution for antigen binding. 
after single immunization. Pretreatment of these sera with 2-mercaptoethanol 
(16) completely abolishes the hemagglutination titer precluding the distinction 
between IgM and IgG antibodies by this method in early sera (17). 
Separation of  IgM and IgG Antibodies in the Sera of  BALB/c Mice Receiving 
Repeated  GAT Immunization.  We  have  used  a  Sephadex  G-200 column to 
physically identify IgM anti-GAT antibodies in the sera of BALB/c mice that 
have received double GAT immunizations. Fig. 1 shows two peaks of hemagglu- 
tinating activity eluted from the column. The larger peak elutes in the void 
volume (marker, blue dextran) corresponding to the (19S) IgM class of antibod- 
ies. The smaller peak elutes at the same volume as BGG and thus corresponds to 
IgG anti-GAT antibodies. Since IgM antibodies are known to hemagglutinate 
more  efficiently than  IgG,  the  size  of the  hemagglutination peaks  do  not 
necessarily reflect the respective amount of antibodies. 
Duration  of the IgM PFC Responses  of BALB/c Mice  to GAT.  Spleens of 
BALB/c mice immunized twice with GAT in Maalox pertussis show an IgM as 
well as an IgG PFC response 7 days after immunization. The data in Table III 
show that IgM and IgG GAT-specific PFC are seen at 4 and 11 days as well as 7 
days after the second immunization. The appearance of GAT-specific IgM PFC 
is, therefore not a transient phenomenon. 
Effect  of  Repeated  Immunization  in  Responder  and  Nonresponder 
Mice.  The data in Table IV show that another GAT-responder strain, C57BL/ 
6, is capable of producing GAT-specific IgM PFC after immunization twice with 
GAT in Maalox-pertussis as described above. Although not shown, the primary 
response of a  limited number of C57BL/6 mice was restricted to the IgG class, 
confirming previously reported results (2). Repeated immunization of a  GAT 
nonresponder strain, DBA/1, with GAT in Maalox pertussis, however, fails to 
stimulate either IgM or IgG PFC responses. 
A characteristic property of GT- or GAT-nonresponder animals is their ability 
to  develop  a  GAT  or  GT-specific responses  when  injected with  GAT  or  GT 
complexed to an immunogenic carrier such as MBSA. Primary responses to GT- 
MBSA and GAT-MBSA were found to be also restricted to IgG class of antibody 
(2, 5). However, nonresponder mice, BALB/c or DBA/1, injected twice with GT- 
MBSA  or  GAT-MBSA,  respectively,  can  mount an  IgM  as  well  as  an  IgG 
antigen-specific PFC response (Table V). 1282  CONTROL  OF  IgG  AND  IgM  RESPONSES 
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Fro.  1.  Separation of IgM and IgG GAT-specific antibodies. A Sephadex G-200 column (1.5 
x  20 cm) was equilibrated in PBS at 4°C. The column was calibrated using Blue dextran 
2000 (BD, 2  x  10  e mol wt), bovine gamma globulin (BGG,  150,000 mol wt), bovine serum 
albumin (BSA, 66,000  mol wt), and cytochrome c  (cyt C,  12,500 mol wt) as markers. The 
serum from BALB/c mice immunized twice with GAT in Maalox pertussis was passed over 
the column. Optical density at 280 nm of the eluate was recorded and the hemagglutination 
titer (HA) of each fraction was determined using GAT-SRBC as indicator cells. (S- •-  @) 
HA titer; (---) optical density. 
Antigenic Suppression of the IgM and IgG PFC Responses of GAT and GT 
Nonresponder  Mice.  Earlier  studies  from  our  laboratory  have  shown  that 
injection  of GT  or  GAT  into  nonresponder  mice  bearing  the  H-2 d  or  H-2  q 
haplotype stimulate suppressor T cells capable of inhibiting antigen-specific IgG 
PFC responses to GT-MBSA or GAT-MBSA, respectively (5,  12). The effect of 
GT preimmunization  on the  IgM  and IgG PFC  responses  of BALB/c mice is 
shown in Table VI. Both IgM and IgG responses are suppressed. Likewise, GAT 
preimmunization  diminishes  considerably the GAT-MBSA IgM and IgG PFC 
responses of DBA/1 mice. It is well documented that the inhibition of IgG PFC 
responses in the GAT and GT systems is due to active suppression mediated by T 
cells (18). 
The data presented in Table VII illustrate that the transfer of 20  ×  l0  s cells 
from GT-primed BALB/c mice results in the suppression of both the IgM and 
IgG PFC responses of BALB/c mice demonstrating,  therefore,  the presence of 
suppressor cells "active" on both IgM and IgG responses in GT-primed mice. 
Discussion 
Previous  studies from our laboratory have  shown that  both responder  and 
nonresponder mice develop only IgG primary responses to GAT, GT, and GA (2- 
5). In the present study, we report the appearance of IgM antibodies in second- 
ary responses to GAT in responder and to GAT-MBSA or GT-MBSA in nonre- 
sponder mice. We have verified the presence of antigen-specific IgM antibodies C.  WALTENBAUGH,  J.  THEZE,  AND  B.  BENACERRAF 
TABLE  III 
Secondary PFC Responses of BALB/c Mice to GAT at Various 
Times after the Second Immunization 
Interval after  GAT-specific PFC per spleen~ 
second injection*  IgM  IgG 
4 days  20,250 ___ 4,360  75,825 ± 11,209 
7 days  23,250 +_ 5,603  67,640 ± 10,526 
11 days  14,240 ± 5,124  22,240 ± 3,784 
* Mice were immunized initially with 50 ~tg GAT in Maalox-pertussis 
i.p.  followed 3 days later by 10  ~g GAT in Maalox-pertussis.  GAT- 
specific PFC were assayed either 4, 7, or 11 days after second injection 
of antigen. 
$ Numbers represent arithmetic mean -+ SE for five mice per group. 
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TABLE  IV 
Effect of  Repeated Immunization with GAT in Responder, C57BL/6, and Nonresponder, 
DBAH, Mice 
Strain 
Immunization*  Number of  GAT-specific PFC per spleens 
Day 0  Day 3  mice/group  IgM  IgG 
Arith. mean  +- SE 
C57BL/6  GAT/MP  GAT/MP  6  15,100 +- 2,822  145,225  ± 30,326 
DBA/1  -  GAT/MP  4  <200  <200 
DBA/1  GAT/MP  GAT/MP  4  <200  <200 
* Mice received 50 ~g GAT in Maalox pertussis intraperitoneally followed 3 days later by 10 ~g 
GAT in Maalox pertussis, intraperitoneally. 7 days later, the number of GAT-specific PFC per 
spleen was determined. 
It was shown earlier that a primary immunization of C57BL/6 with GAT does not elicit an IgM 
response. Although not shown, these results were confirmed using a limited number of animals. 
both functionally by the formation of direct PFC which are totally inhibitable by 
a  well-characterized goat anti-mouse  re-chain antiserum (14) and physically by 
gel filtration on a Sephadex G-200 column. Simultaneous with the appearance of 
the  IgM  antibodies  in  the  secondary  response,  we  have  observed  a  marked 
enhancement in the IgG antibody response, confirmed by both the plaque assay 
and by an antigen-binding  assay. 
The appearance of GAT- or GT-specific antibodies of the IgM class is depend- 
ent upon the repeated administration of antigen.  The quantity of antigen does 
not  appear  to  be  the  critical  parameter  in  these  experiments;  BALB/c  mice 
injected once with 10 ftg GAT (Table I) develop only an IgG response, whereas a 
comparable amount of GAT in two injections stimulates an IgM as well as an 
enhanced IgG response.  In other experiments (not shown)  a  single injection of 
BALB/c mice with 100 ~g GAT in either Maalox pertussis or complete Freund's 
adjuvant did not induce IgM PFC while stimulating strong IgG PFC responses 
4-7 days after primary immunization.  IgM antibodies are induced  even when 
the two injections of antigen are separated by a  21-day interval, characterizing 
this  phenomenon  as  a  secondary  antibody response to these  linear  polymers. 
The appearance of IgM antibodies is not transient;  IgM PFC responses can be 
detected  in  the  plaque  assay 4-11  days  after the  second  injection  of antigen. 1284  CONTROL  OF  IgG  AND  IgM  RESPONSES 
TABLE V 
Effect of Repeated Administration of GT-MBSA or GAT-MBSA in Genetic 
Nonresponder BALB/c and DBA/1 Mice 
Strain 
Immunization*  Antigen-specific PFC per spleens 
Day 0  Day 3  IgM  P  value  IgG  P  value 
Arith. mean  ± SE  Arith. mean  ±  SE 
BALB/c  GT-MBSA  205 ± 5.5  4,708  ±  923 
BALB/c  GT.MBSA  GT-MBSA  12,261 ±  1,709  <0.001  11,283 ±  2,029  0.009 
DBA/1  GAT-MBSA  178 ± 9.8  4,305  ± 573 
DBA/1  GAT.MBSA  GAT-MBSA  16,477 ± 3,635  <0.001  10,569 ±  1,544  0.001 
* Mice were immunized intraperiteneally with either  50 p~g  of  GT as GT-MBSA  or 50 ~g GAT as GAT-MBSA  in Maalox pertuesis 
initially  followed 3 days later  by an i.p.  injection  of  10 p,g  OT as GT-MBSA  or 10/~g OAT as  GAT-MBSA  in Maalox pertussis.  On 
day 10, spleens from these mice were assayed for antigen-specific  PFC. 
~: Nine mice were used per date group. 
Furthermore, the induction of IgM antibodies is not limited to responder ani- 
mals; nonresponder animals produce antigen-specific IgM when either GT or 
GAT complexed to MBSA are administered twice. 
The restriction of primary responses to  GAT,  GA,  GAT-MBSA,  and  GT- 
MBSA to the IgG class together with the requirement of repeated immunization 
to stimulate IgM antibody responses to these antigens raise important issues 
concerning the regulation of class-specific  antibody responses and challenge the 
generally accepted belief  that IgM antibody responses (when they occur) are the 
earliest antibody responses and always precede IgG antibody responses, particu- 
larly  after primary immunization.  These  conclusions were  based  upon  the 
responses to particulate antigens such as SRBC and bacteria and also upon the 
result of immunization with antigens that have a thymus-independent as well 
as a thymus-dependent  component, such as (T,G)-A--L or polymerized flagellin. 
The strong possibility must be entertained that the commitment to early IgM 
responses  is  a  property of thymus-independent antigens,  whereas thymus- 
dependent antigens which require the activity of helper T cells and often elicit 
the regulatory activity of specific suppressor T cells may sometimes stimulate 
primary IgG and secondary IgM responses as seen in the current experiments. 
The appearance of IgM in the secondary antibody response in our experiments 
may be explained by the existence of two helper T-cell populations, one specific 
for IgM responses and the other for IgG.  Differential activation of these two 
populations could explain why IgG helper cells might be triggered after only a 
single injection of antigen, while IgM helpers would require a second injection of 
antigen for stimulation. An alternative hypothesis would be that injection of 
antigen into responder animals leads to the stimulation of both antigen-specific 
helper and suppressor T  cells.  The suppressor cells stimulated after a  single 
injection of antigen may preferentially affect the IgM response, therefore, the 
effect of the  helpers  would  lead  to  the  production  of only  IgG  antibodies. 
According to  this  hypothesis,  a  second injection of antigen would shift the 
helper-suppressor balance in favor of the helper cells explaining the appearance 
of IgM and the enhancement of IgG antibody levels. Both hypotheses also apply 
to genetic nonresponder animals when the relevant linear polymer is coupled to 
an immunogenic carrier-protein such as MBSA. 
Our recent studies have demonstrated the stimulation of specific suppressor T C.  WALTENBAUGH,  J.  THI~,ZE,  AND  B.  BENACERRAF  1285 
TABLE VI 
Effect of GT or GAT Preimmunization on the IgM or IgG PFC Responses of BALR/c or 
DBA/1 Mice to GT-MBSA or GAT-MBSA, Respectively 
Strain  Immunization  Number of 
mice/group 
Antigen-specific PFC per spleen* 
IgM  P  value  IgG  P  value 
Arith. mean  ± SE  Arith. mean  ± SE 
BALB/c  -  GT-MBSA*  10  23,140 ± 4,209  12,680 ±  1,331 
BALB/c  GT$  GT-MBSA  10  620 ±  265  0.002  360 ±  22  <0.001 
DBA/1  -  GAT-MBSA*  9  17,677 -+ 3,577  9,822 ±  1,371 
DBA/1  GAT*  GAT-MBSA  10  3,710 ±  1,710  0.002  475 ± 34  <0.001 
* Mice were immunized intraperitoneally with 50 p.g GT as GT-MBSA  or 50 p.g GAT as GAT-MBSA  in Maalox pertuesis followed 3 
days later by 10 p.g GT as GT-MBSA or 10/zg GAT as GAT-MBSA in Maalox pertussis. 7 days after second antigen-MBSA 
injection  the number of PFC per spleen  was determined. 
$ Mice were preirnmnnized with 100 pg GT or 10 ~tg GAT in Maalox. 
TABLE VII 
Effect of Transfer of Normal or GT-Primed Spleen Cells on the Primary and Secondary 
PFC Responses of BALB/c Mice to GT-MBSA 
Cells  Immunizations 
Number of 
transferred:* 
Day 0  Day 3  Day 6  mice/group 
GT-specific  PFC per spleen 
IgM  P  value  IgG  P  value 
Arith. mean  ± SE  Arith. mean  ± SE 
-  GT-MBSA  4  ND§  10,750 ±  900 
GT primed  -  GT-MBSA  4  ND  450 ±  250  <0.001 
-  GT-MBSA  OT-MBSA  6  13,700 ±  2,328  13,433 -+ 2,577 
Normal  GT-MBSA  GT-MBSA  6  10,841 ± 821  0.27  11,875 ±  1,669  0.62 
GT primed  GT-MBSA  GT-MBSA  6  275 _+ 25  0.001  270 ± 50  0.001 
* BALB/c spleen cells (20 x  10  e) from normal mice or mice that had received  100/zg GT in Maaiox 3 days earlier were injected 
intravenously  into normal BALB/c mice. 
$ Mice were immunized with i or 2 injections  of GT-MBSA. Primary responses were elicited by injecting  10 ~g of GT as GT-MBSA, 
i.p. Mice were initially  injected intraperitoneally with 50/zg of GT as GT-MBSA followed 3 days later by an i.p. injection of 10 ~g 
GT as GT-MBSA for secondary responses.  7 days al%er the 10 pg injection  spleens were assayed  for antigen-specific  PFC. 
§ ND, not determined. 
cells in nonresponder mice by GAT and in selected nonresponder strains by GT. 
These suppressor T cells were found to suppress the primary IgG responses to 
GAT-MBSA  and  GT-MBSA  (5,  12,  18).  In  this  report,  we  have  shown  that 
preimmunization  with the appropriate  copolymer  inhibits  the secondary  IgM 
and IgG responses in nonresponder animals to GAT-MBSA or GT-MBSA.  The 
tolerance observed is due to the induction of suppressor cells as demonstrated by 
cell transfer experiments (Table VII). We can extend the above two hypotheses 
to explain suppression in nonresponder animals.  Suppression can be explained 
either by two populations of suppressor cells each acting separately on the IgM 
and  IgG responses  or by  one  population  of suppressor  cells  working  on both 
responses. Experiments are currently in progress to resolve these two models. 
Summary 
Primary responses to the linear polymers of L-glutamic acid, L-tyrosine, and L- 
alanine are restricted to the IgG class of antibodies.  The appearance of specific 
IgM antibodies against these antigens is dependent upon secondary immuniza- 
tion,  in contrast to many classical  antigenic  systems.  The presence of an IgM 
response  was verified  by a  direct  plaque-forming cell  assay,  the inhibition  of 
direct  plaques  by  an  antiserum  specific  for  mouse  /z-chain,  and the  physical 1286  CONTROL  OF  IgG  AND  IgM  RESPONSES 
separation of IgM and IgG GAT-specific antibodies by gel filtration. Preimmuni- 
zation of the appropriate nonresponder strain with GAT or GT inhibits both the 
secondary IgM and IgG responses to GAT-MBSA and GT-MBSA, respectively. 
The tolerance  observed is  due  to the  induction  of suppressor  cells  as  demon- 
strated by cell transfer experiments. 
We thank Dr. Judith A. Kapp for numerous suggestions and discussions, Linda Kapp and William 
Kwoka for excellent  technical  assistance,  and Mrs. Sharon Smith for skilled preparation of this 
manuscript. 
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